Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Sygnis AG. (11/18/16). "Press Release: Sygnis AG to Present at Upcoming Investor Conferences". Madrid & Heidelberg.

Organisations Organisation Sygnis AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard)
  Group Genetrix (ES) (Group)
  Organisation 2 Deutsche Börse AG
  Today Deutsche Börse (Group)
  Group Deutsche Börse (Group)
Products Product Deutsches Eigenkapitalforum 2016 Frankfurt (German Equity Forum 2016)
  Product 2 22. MKK – Münchner Kapitalmarkt Konferenz 2016 Munich
Index terms Index term Genetrix (ES)–Deutsche Börse: investor conference, 201611 supply service Sygnis AG presents at Deutsches Eigenkapitalforum 2016
  Index term 2 Genetrix (ES)–GBC: investor conference, 201612 supply service Sygnis AG presents at MKK Münchner Kapitalmarkt Konferenz 2016
Persons Person Lanckriet, Heikki (Expedeon 201111 CEO + Founder)
  Person 2 de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia)
     


SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the attendance at two major German investor conferences in November and December 2016.


German Equity Forum hosted by Deutsche Börse AG
Date of attendance: 21 and 22 November 2016
Presentation time: Monday, 21 November 2016, 17:00 - 17:30 pm CET, Room Oslo
Venue: Frankfurt/Main, Germany, Sheraton Frankfurt Airport Hotel and Conference Center
Presenting and available for meetings: Dr. Heikki Lanckriet, Co-CEO and CSO, Pilar de la Huerta, Co-CEO/CFO
More information: http://www.eigenkapitalforum.com/

22nd Munich Capital Markets Conference (MKK) hosted by GBC AG
Date of attendance: 7 and 8 December 2016
Presentation time: Tuesday, 7 December 2016, 12:20 - 13:00 pm CET, Room GBC III
Venue: Munich, Germany, The Charles Hotel
Presenting and available for meetings: Dr. Heikki Lanckriet, Co-CEO and CSO, Pilar de la Huerta, CEO/CFO
More information: http://www.mkk-investor.de/


If you would like to meet us, please contact for both conferences: contact@mc-services.eu or via phone: +49 89 210 228-0.


For further information, please contact:

SYGNIS AG
Pilar de la Huerta
Co-CEO/CFO
Phone: +34 91 192 36 50
Email: pdelahuerta@sygnis.com

MC Services AG
Raimund Gabriel
Managing Partner
Phone: +49 89 210228 0
Email: raimund.gabriel@mc-services.eu


About SYGNIS AG: www.sygnis.com

SYGNIS AG is specialized in the development and the commercialization of proprietary technologies and offers a wide range of different commercial products addressing key challenges in molecular biology. With the acquisition of Expedeon Holdings, Ltd. based in Cambridge, UK, SYGNIS has added a complementary proteomic product portfolio. Resulting from this significant expansion, SYGNIS’ product portfolio now covers the entire workflow of molecular biology. The products are sold through a direct sales force and several distribution partners in Europe, the US and Asia. SYGNIS AG has offices in Germany, Spain and the UK, production sites in the UK and the US as well as sales offices in Asia. The company is listed on the German Stock Exchange in Frankfurt in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03).

### This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward-looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of SYGNIS AG may deviate greatly from the established conclusions or implied predictions contained in such statements. SYGNIS does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason.###

Madrid, Spain/Heidelberg, Germany
SYGNIS AG, Waldhofer Str. 104, 69123 Heidelberg, Germany, www.sygnis.de, Tel.: +49 6221 3540 125, Fax: +49-6221- 3540-127

   
Record changed: 2017-07-02

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Genetrix (ES) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px